---
title: "VSee Health Secures $575,550 In Convertible Notes From ClearThink and Vanquish; 2027 Maturities"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291974244.md"
description: "VSee Health secured $575,550 in unsecured convertible notes to enhance liquidity. The company issued a $280,000 note to ClearThink (10% interest, maturing Jun 2027) and a $295,550 note to Vanquish (12% interest, maturing Apr 2027). Both notes allow conversion after 180 days based on stock price metrics, subject to ownership caps."
datetime: "2026-07-07T20:23:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291974244.md)
  - [en](https://longbridge.com/en/news/291974244.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291974244.md)
generator: "portal-rs"
---

# VSee Health Secures $575,550 In Convertible Notes From ClearThink and Vanquish; 2027 Maturities

VSee Health entered two unsecured convertible note financings totaling $575,550 to strengthen liquidity. The company issued a $280,000 note to ClearThink with a one-time 10% interest charge, and a $295,550 note to Vanquish with a one-time 12% interest charge. The ClearThink note matures on Jun 22, 2027 and is prepayable without penalty, with conversion after 180 days at 85% of the lowest 10-day closing price, subject to a $0.01 floor and a 4.99% ownership cap. The Vanquish note is due Apr 15, 2027, features prepayment premiums, and allows conversion after 180 days and upon an event of default at 75% of the lowest 10-day closing bid, with a 4.99% cap and no reverse-split adjustment.

**Agreement 1: VSee Health Secures $280,000 ClearThink Convertible Note; 10% One-Time Interest, 2027 Maturity**

-   **Agreement type**: Unsecured convertible note
-   **Counterparty**: ClearThink
-   **Signed / Effective**: Jun 22 2026 / same
-   **Duration / Termination**: Due Jun 22 2027
-   **Reason**: Enhance liquidity and financial flexibility

**Agreement 2: VSee Health Adds $295,550 Vanquish Convertible Note; 12% One-Time Interest, Apr 2027 Due**

-   **Agreement type**: Unsecured convertible note
-   **Counterparty**: Vanquish
-   **Signed / Effective**: Jun 18 2026 / same
-   **Duration / Termination**: Due Apr 15 2027
-   **Reason**: Enhance liquidity and financial flexibility

Original SEC Filing: VSEE HEALTH, INC. \[ VSEE \] - 8-K - Jul. 07, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [VSEE.US](https://longbridge.com/en/quote/VSEE.US.md)
- [VSEEW.US](https://longbridge.com/en/quote/VSEEW.US.md)
- [CTAA.US](https://longbridge.com/en/quote/CTAA.US.md)

## Related News & Research

- [VSee Health enters USD 336,000 convertible note financing with Labrys](https://longbridge.com/en/news/294553005.md)
- [Valmet updates 2027 financial reporting calendar](https://longbridge.com/en/news/297521285.md)
- [Planet Labs Q2 2027 Earnings Preview](https://longbridge.com/en/news/297834133.md)
- [Sprinklr Q2 2027 Earnings Preview](https://longbridge.com/en/news/297689908.md)
- [PCG: Strategic review launched with $2B in 2027 capex deferrals and updated EPS guidance](https://longbridge.com/en/news/297783125.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**